Mundipharma launches first augmented reality app, breathrite to help asthma sufferers

breatherite app Credit: Mundipharma

Mundipharma recently launched the Asthma management app, breatheriteTM in Singapore as a part of their inaugural digital health initiative to deliver improved patient outcomes in response to unmet patient and doctor needs.

This free app available in Play store and iOS, utilizes augmented reality together with a range of smartphone sensors, to deliver a personal asthma management solution with a focus on correcting errors in inhaler technique. This app is currently available for downloading in Singapore and Philippines stores.

Like the popular social App, Snapchat, thebreatheriteTM App engages the front-facing camera for facial mapping, accelerometer and gyrometer to track inhaler preparation, the microphone to analyse inhalation and exhalation, along with augmented reality to visualise correct inhaler orientation and head alignment.

In a 2016 large independent study, “The Systematic Review of Errors Inhaler Technique” 144 articles reporting on a total number of 54,354 subjects were summarized. The study concluded that:

“Incorrect inhaler technique is unacceptably frequent and has not improved over the past 40 years, pointing to an urgent need for new approaches to education and drug delivery.”

Together, these features assess, and correct inhaler use as part of a unique interactive experience. It also enables patients to set medication reminders, receive lifestyle tips, real-time weather and air quality information.

breatherite app. Patient profiling

breatheriteTM also delivers a personal experience by profiling patients based on their attitudes towards Asthma management. Their symptoms and control measures are also tracked within the app. This information can be shared by the patient with their doctors to improve communication and better understand the patient’s condition while also helping to manage the day-to-day treatment of Asthma.

“Achieving good asthma control is vital to reduce chronic symptoms such as coughing and shortness of breath, minimise the reliance on relief medications, and maintain good lung function. This app will help patients take charge of asthma and has potential to improve quality of life through real-time monitoring of inhaler use and overall asthma management,” says Adjunct Associate Professor Augustine Tee, Senior Consultant and Chief, Respiratory and Critical Care Medicine, Changi General Hospital, and Vice President of the Asthma and Allergy Association.

Research shows that there is an opportunity to improve the level of Asthma control among patients in Asia-Pacific, where more than 70% of patients overestimate their level of control and only 50% of physicians check their patient’s inhaler technique frequently. Low levels of Asthma control have been identified to be largely due to incorrect inhaler technique including poor coordination, inadequate speed and depth of inhalation and post-inhalation breath holding.

Patient problems are compounded when prescribed with multiple inhaler devices, with only an estimated 31% of patients performing correct inhaler technique. breatheriteTM is designed to be used with the majority of inhaler types that patients are prescribed.

Mundipharma CEO Raman Singh

“The high rates of smartphone penetration across emerging markets and the inbuilt processing power of today’s mobile devices together with the increasing maturity of augmented reality technology have combined to create a real opportunity to tackle this decades old problem,” said Mundipharma CEO Raman Singh. “With World Asthma Day approaching, we are proud to launch this unparalleled new solution, which gives people with Asthma an opportunity to take greater control of their condition.”